Application of Artificial intelligence in oncologic molecular PET-imaging: a narrative review on beyond [18F] F-FDG tracers-part I. PSMA, choline, and DOTA radiotracers SA Mirshahvalad, R Eisazadeh, M Shahbazi-Akbari, C Pirich, M Beheshti Seminars in Nuclear Medicine 54 (1), 171-180, 2024 | 10 | 2024 |
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F] F-FDG Tracers Part II.[18F] F-FLT,[18F] F-FET,[11C] C-MET and … R Eisazadeh, M Shahbazi-Akbari, SA Mirshahvalad, C Pirich, M Beheshti Seminars in Nuclear Medicine, 2024 | 8 | 2024 |
Pre-treatment 68 Ga-PSMA-11 PET/CT Prognostic Value in Predicting Response to 177Lu-PSMA-I&T Therapy and Patient Survival R Eisazadeh, SA Mirshahvalad, G Schwieghofer-Zwink, L Hehenwarter, ... Molecular Imaging and Biology 26 (2), 360-369, 2024 | 3 | 2024 |
18F-FDG PET/CT prognostic role in predicting response to salvage therapy in relapsed/refractory Hodgkin's lymphoma R Eisazadeh, SA Mirshahvalad Clinical Imaging 92, 25-31, 2022 | 3 | 2022 |
Impact of [18F]FDG PET/CT in the Assessment of Immunotherapy-Induced Arterial Wall Inflammation in Melanoma Patients Receiving Immune Checkpoint Inhibitors S Ranjbar, SR Zakavi, R Eisazadeh, SA Mirshahvalad, J Pilz, ... Diagnostics 13 (9), 1617, 2023 | 1 | 2023 |
Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review N Mohseninia, R Eisazadeh, SA Mirshahvalad, N Zamani-Siahkali, ... Seminars in Nuclear Medicine, 2025 | | 2025 |
Automatic detection and segmentation of lesions in 18F-FDG PET/CT imaging of patients with Hodgkin lymphoma using 3D dense U-Net MA Izadi, N Alemohammad, P Geramifar, A Salimi, Z Paymani, ... Nuclear Medicine Communications 45 (11), 963-973, 2024 | | 2024 |
Can a cutoff be set for pre-treatment 68Ga-PSMA-11 PET/CT parameters to predict 177Lu-PSMA-I&T response and patient survival? S Mirshahvalad, R Eisazadeh, G Rendl, S Gampenrieder, ... EUR J NUCL MED MOL IMAGING 50 (SUPPL 1), S651-S651, 2023 | | 2023 |